Hormone-sensitive Prostate Cancer
📧 Sign up to get email alerts when something new happens for Hormone-sensitive Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer [Phase 3]
Phase 3 trial evaluating darolutamide added to standard androgen deprivation therapy and docetaxel in metastatic hormone-sensitive prostate …
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer [Phase 2, Phase 3]
Clinical trial update for immunotherapy strategies in metastatic hormone-sensitive prostate cancer (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating the efficacy and safety of docetaxel combined with platinum in metastatic hormone-sensitive prostat…
-
CLINICAL_TRIALS withdrawal · 2018-07-17Clinical Trial Update: Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) [Phase 1, Phase 2]
Clinical trial update on toxicity and pharmacokinetics of 2- and 3-weekly docetaxel in Metastatic Hormone-Sensitive Prostate Cancer. The stu…